Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-093924
Filing Date
2025-07-03
Accepted
2025-07-07 12:11:40
Documents
25
Period of Report
2025-07-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A apvo-20250702.htm   iXBRL DEF 14A 1576961
2 GRAPHIC img136411087_0.jpg GRAPHIC 45134
3 GRAPHIC img136411087_1.jpg GRAPHIC 45134
4 GRAPHIC img136411087_2.jpg GRAPHIC 45134
5 GRAPHIC img136411087_3.jpg GRAPHIC 45134
6 GRAPHIC img136411087_4.jpg GRAPHIC 45134
7 GRAPHIC img136411087_5.jpg GRAPHIC 47859
8 GRAPHIC img136411087_6.jpg GRAPHIC 45134
9 GRAPHIC img136411087_7.jpg GRAPHIC 45134
10 GRAPHIC img136411087_8.jpg GRAPHIC 45134
11 GRAPHIC img136411087_9.jpg GRAPHIC 353400
12 GRAPHIC img136411087_10.jpg GRAPHIC 65121
13 GRAPHIC img136411087_11.jpg GRAPHIC 204521
  Complete submission text file 0000950170-25-093924.txt   4475355

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apvo-20250702.xsd EX-101.SCH 7954
27 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20250702_htm.xml XML 203052
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37746 | Film No.: 251107670
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)